SGMT compared with RACC: revenue, margins and what each company keeps, and the suppliers and customers both name

SGMTSagimet Biosciences Inc.

Mkt capRevenueRevenue

RACCResearch Alliance Corp III

Mkt capRevenueRevenue

Compare

SGMTSagimet Biosciences Inc.

RACCResearch Alliance Corp III

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

SGMT1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.4%▼−0.52%×0.04

RACC

No earnings history for RACC.

= impliedSGMT realized, solidRACC realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

SGMTSagimet Biosciences Inc.

9.96▲+2.79%· post 9.96

Mkt cap$602.3MRevenue$2MQ3 FY23

RACCResearch Alliance Corp III

10.14▲+0.42%· post 10.10

ClosedNov 3 '26

Mkt cap$48.9MRevenue—

Compare

ClosedNov 3 '26

SGMTSagimet Biosciences Inc.

RACCResearch Alliance Corp III

9.96▲+2.79%post 9.96

Price

10.14▲+0.42%post 10.10

$602.3M

Mkt cap

$48.9M

Q3 FY23$2M

Revenue

—

SGMT9.96▲+2.79%vsRACC10.14▲+0.42%ClosedNov 3 '26